Smooth muscle-specific gene delivery in the vasculature based on restriction of DNA nuclear import

Experimental Biology and Medicine

Volumn 233, Issue 7, 2008, Pages 840-848

  Young, Jennifer L ^a   Zimmer, Warren E ^b   Dean, David A ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY SYSTEM   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Cell specific; Electroporation; Nuclear import; Plasmid; Vasculature

Indexed keywords

ACTIN; PLASMID DNA; DNA;

ANIMAL EXPERIMENT; ARTICLE; CELL NUCLEUS TRANSPLANTATION; CONTROLLED STUDY; DNA TRANSFER; ELECTROPORATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; IN VIVO STUDY; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; VASCULARIZATION; ACTIVE TRANSPORT; ANIMAL; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PHYSIOLOGY; PLASMID; PROMOTER REGION; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

RATTUS;

ACTINS; ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; DNA; ELECTROPORATION; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; MALE; MUSCLE, SMOOTH, VASCULAR; PLASMIDS; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY;

EID: 47749088627     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0712-RM-331     Document Type: Article

References (36)

1. Beck C, Uramoto H, Boren J, Akyurek LM. Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challenges. Curr Gene Ther 4:457-467, 2004.
2. Young JL, Dean DA. Non-viral gene transfer strategies for the vasculature. Microcirculation Res 9:35-50, 2002.
3. Dean DA. Import of plasmid DNA into the nucleus is sequence specific. Exp Cell Res 230:293-302, 1997.
4. Langle-Rouault F, Patzel V, Benavente A, Taillez M, Silvestre N, Bompard A, Sczakiel G, Jacobs E, Rittner K. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J Virol 72:6181-6185, 1998.
5. Dean DA, Dean BS, Muller S, Smith LC. Sequence requirements for plasmid nuclear entry. Exp Cell Res 253:713-722, 1999.
6. Vacik J, Dean BS, Zimmer WE, Dean DA. Cell-specific nuclear import of plasmid DNA. Gene Ther 6:1006-1014, 1999.
7. Mesika A, Grigoreva I, Zohar M, Reich Z. A regulated, NFkappaB-assisted import of plasmid DNA into mammalian cell nuclei. Mol Ther 3:653-657, 2001.
8. Li S, MacLaughlin FC, Fewell JG, Gondo M, Wang J, Nicol F, Dean DA, Smith LC. Muscle-specific enhancement of gene expression by incorporation of the SV40 enhancer in the expression plasmid. Gene Ther 8:494-497, 2001.
9. Young JL, Benoit JN, Dean DA. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature. Gene Ther 10:1465-1470, 2003.
10. Dean DA, Strong DD, Zimmer WE. Nuclear entry of nonviral vectors. Gene Ther 12:881-890, 2005.
11. Carson JA, Fillmore RA, Schwartz RJ, Zimmer WE. The smooth muscle gamma-actin gene promoter is a molecular target for the mouse bagpipe homologue, mNkx3-1, and serum response factor. J Biol Chem 275:39061-39072, 2000.
12. Browning CL, Culberson DE, Aragon IV, Fillmore RA, Croissant JD, Schwartz RJ, Zimmer WE. The developmentally regulated expression of serum response factor plays a key role in the control of smooth muscle-specific genes. Dev Biol 194:18-37, 1998.
13. Martin JB, Young JL, Benoit JN, Dean DA. Gene transfer to intact mesenteric arteries by electroporation. J Vasc Res 37:372-380, 2000.
14. Nishikawa M. Development of cell-specific targeting systems for drugs and genes. Biol Pharm Bull 28:195-200, 2005.
15. Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 270:18997-19007, 1995.
16. Capecchi MR. High efficiency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22:479-488, 1980.
17. Mesika A, Kiss V, Brumfeld V, Ghosh G, Reich Z. Enhanced intracellular mobility and nuclear accumulation of DNA plasmids associated with a karyophilic protein. Hum Gene Ther 16:200-208, 2005.
18. Arhel NJ, Souquere-Besse S, Charneau P. Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels. Retrovirology 3:38, 2006.
19. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101:173-185, 2000.
20. Vaysse L, Harbottle R, Bigger B, Bergau A, Tolmachov O, Coutelle C. Development of a self-assembling nuclear targeting vector system based on the tetracycline repressor protein. J Biol Chem 279:5555-5564, 2004.
21. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468, 1990.
22. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genetics 1:363-369, 1992.
23. Wolff JA, Dowty ME, Jiao S, Repetto R, Berg RK, Ludtke JJ, Williams P, Slautterback DB. Expression of naked plasmids by cultured myotubes and entry into T tubules and caveolae of mammalian skeletal muscle. J Cell Sci 103:1249-1253, 1992.
24. Doh SG, Vahlsing HL, Hartikka J, Liang X, Manthorpe M. Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA. Gene Ther 4:648-663, 1997.
25. Hartikka J, Sawdey M, Cornefert-Jensen F, Margalith M, Barnhart K, Nolasco M, Vahlsing HL, Meek J, Marquet M, Hobart P, Norman J, Manthorpe M. An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum Gene Ther 7:1205-1217, 1996.
26. Manthorpe M, Cornefert-Jensen F, Hartikka J, Felgner J, Rundell A, Margalith M, Dwarki V. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 4:419-431, 1993.
27. Blomberg P, Eskandarpour M, Xia S, Sylven C, Islam KB. Electro-poration in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle. Biochem Biophys Res Commun 298:505-510, 2002.
28. Prasad TK, Rao NM. The role of plasmid constructs containing the SV40 DNA nuclear-targeting sequence in cationic lipid-mediated DNA delivery. Cell Mol Biol Lett 10:203-215, 2005.
29. Utvik JK, Nja A, Gundersen K. DNA injection into single cells of intact mice. Hum Gene Ther 10:291-300, 1999.
30. Gasiorowski JZ, Dean DA. Postmitotic nuclear retention of episomal plasmids is altered by DNA labeling and detection methods. Mol Ther 12:460-467, 2005.
31. Dean BS, Byrd JN Jr, Dean DA. Nuclear targeting of plasmid DNA in human corneal cells. Cur Eye Res 19:66-75, 1999.
32. Zhou R, Dean DA. Gene transfer of interleukin 10 to the murine cornea using electroporation. Exp Biol Med (Maywood) 232:362-369, 2007.
33. MacDonald RJ, Swift GH. Analysis of transcriptional regulatory regions in vivo. Int J Dev Biol 42:983-994, 1998.
34. Qian J, Kumar A, Szucsik JC, Lessard JL. Tissue and developmental specific expression of murine smooth muscle gamma-actin fusion genes in transgenic mice. Dev Dyn 207:135-144, 1996.
35. Kovacs AM, Zimmer WE. Cell specific transcription of the smooth muscle γ-actin gene requires both positive and negative acting cis-elements. Gene Exp 7:115-129, 1998.
36. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 8:1539-1546, 2001.